Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gábor Holló & Andreas Katsanos. (2015) Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma. Expert Opinion on Drug Safety 14:4, pages 609-617.
Read now
Read now
Yang Liu & Weiming Mao. (2013) Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma. Clinical Ophthalmology 7, pages 7-14.
Read now
Read now
Sıtkı Samet Ermiş. (2012) Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma. Clinical Ophthalmology 6, pages 673-678.
Read now
Read now
Kevin Kaplowitz & James C Tsai. (2012) Tafluprost in the treatment of glaucoma. Expert Review of Ophthalmology 7:5, pages 401-407.
Read now
Read now
Anton Hommer & Friedemann Kimmich. (2011) Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost. Clinical Ophthalmology 5, pages 623-631.
Read now
Read now
Articles from other publishers (17)
Ahmed Essam Faseeh, Riham SHM Allam, Ahmed B Shalash & Mai Nasser Abd Elmohsen. (2021) Comparison between Latanoprost, Travoprost, and Tafluprost in reducing intraocular pressure fluctuations in patients with glaucoma. European Journal of Ophthalmology 31:6, pages 3018-3026.
Crossref
Crossref
Gyeong Min Lee & Seung Joo Ha. (2021) Travoprost- and Tafluprost-induced Changes in Intraocular Pressure and Ocular Pulse Amplitude. Journal of the Korean Ophthalmological Society 62:9, pages 1235-1242.
Crossref
Crossref
Joon-Mo Kim, Kyung-Rim Sung, Hwang-Ki Kim, Sang-Woo Park, Eun-Ji Lee, Jin-Wook Jeoung, Hae-Young Lopilly Park, Jaehong Ahn, Chungkwon Yoo & Chan-Yun Kim. (2021) Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study). Journal of Clinical Medicine 10:12, pages 2717.
Crossref
Crossref
Wissam Georges El Hajj Moussa, Rebecca Georges Farhat, Joseph Claud Nehme, Marwan Antoun Sahyoun, Alexandre Raymond Schakal, Alexandre Edmond Jalkh, Mariana Pierre Abi Karam & Georges Georges Azar. (2018) Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients. Journal of Ophthalmology 2018, pages 1-7.
Crossref
Crossref
Gábor Holló, Andreas Katsanos, Kostas G. Boboridis, Murat Irkec & Anastasios G. P. Konstas. (2017) Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. Drugs 78:1, pages 39-64.
Crossref
Crossref
Chandrasekar Durairaj. (2014) Optimal Sampling Scheme for Estimation of Intraocular Pressure Diurnal Curves in Glaucoma Trials. Clinical Pharmacokinetics 54:1, pages 95-105.
Crossref
Crossref
Liang Lin, Ying Jiao Zhao, Paul T.K. Chew, Chelvin C. A. Sng, Hon-Tym Wong, Leonard W. Yip, Tuck Seng Wu, Dianne Bautista, Monica Teng, Ai Leng Khoo & Boon Peng Lim. (2014) Comparative Efficacy and Tolerability of Topical Prostaglandin Analogues for Primary Open-Angle Glaucoma and Ocular Hypertension. Annals of Pharmacotherapy 48:12, pages 1585-1593.
Crossref
Crossref
Jonghoon ShinJi-Woong LeeBeom-Seok ChoiEun-Young YunJae-Ho JungEun-Ah KimJoseph Caprioli. (2014) The Circadian Changes of Intraocular Pressure and Ocular Perfusion Pressure After Tafluprost Compared with Travoprost in Normal Tension Glaucoma. Journal of Ocular Pharmacology and Therapeutics 30:10, pages 803-809.
Crossref
Crossref
Yasuaki Kuwayama & Akio Nomura. (2014) Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety. Advances in Therapy 31:4, pages 461-471.
Crossref
Crossref
Rei Sakata, Shiroaki Shirato, Kazunori Miyata & Makoto Aihara. (2014) Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution. Japanese Journal of Ophthalmology 58:2, pages 212-217.
Crossref
Crossref
Deepak Sambhara & Ahmad A. Aref. (2013) Glaucoma management: relative value and place in therapy of available drug treatments. Therapeutic Advances in Chronic Disease 5:1, pages 30-43.
Crossref
Crossref
Anastasios G P Konstas, Luciano Quaranta, Andreas Katsanos, Ivano Riva, James C Tsai, Theodoros Giannopoulos, Irini C Voudouragkaki, Eleni Paschalinou, Irene Floriani & Anna-Bettina Haidich. (2013) Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension. British Journal of Ophthalmology 97:12, pages 1510-1515.
Crossref
Crossref
R. Giménez-Gómez, M.R. García-Catalán & J.M. Gallardo-Galera. (2013) Tear clearance and ocular symptoms in patients treated with preservative-free prostaglandins. Archivos de la Sociedad Española de Oftalmología (English Edition) 88:3, pages 88-91.
Crossref
Crossref
R. Giménez-Gómez, M.R. García-Catalán & J.M. Gallardo-Galera. (2013) Aclaramiento lagrimal y sintomatología ocular en pacientes tratados con prostaglandinas sin conservantes. Archivos de la Sociedad Española de Oftalmología 88:3, pages 88-91.
Crossref
Crossref
Hee Young ChoiJi Eun LeeJi Woong LeeHyun Jun ParkJi Eun LeeJae Ho Jung. (2012)
In Vitro
Study of Antiadipogenic Profile of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in Human Orbital Preadiopocytes
. Journal of Ocular Pharmacology and Therapeutics 28:2, pages 146-152.
Crossref
Crossref
Stefano Ranno, Matteo Sacchi, Cinzia Brancato, Daniela Gilardi, Andrea Lembo & Paolo Nucci. (2012) A Prospective Study Evaluating IOP Changes after Switching from a Therapy with Prostaglandin Eye Drops Containing Preservatives to Nonpreserved Tafluprost in Glaucoma Patients. The Scientific World Journal 2012, pages 1-6.
Crossref
Crossref
Mina B. Pantcheva, Leonard K. Seibold, Nida S. Awadallah & Malik Y. Kahook. (2011) Tafluprost: a novel prostaglandin analog for treatment of glaucoma. Advances in Therapy 28:9, pages 707-715.
Crossref
Crossref